




Instance: composition-en-a651c9ffaada5f4880461c8764acc607
InstanceOf: CompositionUvEpi
Title: "Composition for dukoral Package Leaflet"
Description:  "Composition for dukoral Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpa651c9ffaada5f4880461c8764acc607)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - dukoral"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet:</p>
<ol>
<li>What Dukoral is and what it is used for </li>
<li>What you need to know before you use Dukoral </li>
<li>How to use Dukoral </li>
<li>Possible side effects </li>
<li>How to store Dukoral </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What dukoral is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What dukoral is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dukoral is an oral vaccine against cholera that stimulates the immunological defence in the gut. The 
vaccine protects adults and children from 2 years of age against cholera.  </p>
<p>Dukoral causes your body to produce its own protection against cholera. After getting the vaccine, 
your body will make substances called antibodies, which fight the cholera bacteria and toxin that 
cause diarrhoea.  </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take dukoral"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take dukoral"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not use Dukoral 
* if you are allergic to any ingredient of the vaccine or to formaldehyde. 
* if you have an acute stomach disorder or infection with fever (vaccination should be delayed). </p>
<p>Warnings and precautions 
Talk to your doctor before taking Dukoral 
  if you take a medical treatment that affects the immune system <br />
  if you have a disease of the immune system (including HIV infection).<br />
The vaccine may provide you with a lower level of protection than it does for people with healthy 
immune systems. </p>
<p>The vaccine does not provide complete protection and it is important to adhere to dietary and hygiene 
advice to avoid diarrhoeal diseases. </p>
<p>Children 
Do not give this vaccine to children younger than 2 years since the protection has not been studied in 
this group. </p>
<p>Other medicines and Dukoral 
Please tell your doctor if you are taking or have recently taken any other medicines. 
Do not take other medicine starting 1 hour before until 1 hour after taking the vaccine.<br />
Using Dukoral with food and drink 
Avoid food and drink starting 1 hour before until 1 hour after the vaccination. </p>
<p>Pregnancy and breast-feeding 
If you are pregnant, think you may be pregnant or are planning to have a baby or are breast-feeding, 
ask your doctor before taking the vaccine.  </p>
<p>Driving and using machines 
 There are no reasons to suspect that Dukoral will affect your ability to drive or handle machines </p>
<p>Dukoral contains sodium 
Dukoral contains approximately 1.1 g sodium per dose. Please take this into consideration if you are 
on a controlled sodium diet. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take dukoral"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take dukoral"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always use this medicine exactly as described in this leaflet or as your doctor has told you. Check 
with your doctor if you are not sure. 
Adults and children from 6 years of age: The primary vaccination is 2 doses taken orally (by mouth) 
at least 1 week (up to 6 weeks) apart.<br />
  Take the 1st dose no later than 2 weeks before you leave for your trip. 
  Take the 2nd dose at least 1 week after the 1st dose and at least 1 week before your trip.<br />
It takes about 1 week after the last dose for protection to begin. 
For continuous protection, re-vaccination is recommended within 2 years. If you had your last dose of 
vaccine less than 2 years ago a single dose will renew your protection. If more than 2 years have 
passed since you had the last vaccine dose, the primary vaccination (2 doses) should be repeated. </p>
<p>Children of 2 to below 6 years of age: The primary vaccination is 3 doses taken orally (by mouth) at 
least 1 week (up to 6 weeks) apart. Only half of the amount of the buffer solution should be mixed 
with the vaccine.<br />
  Give the 1st dose to the child no later than 3 weeks before you leave for your trip.<br />
  Give the 2nd dose to the child at least 1 week after the 1st dose.<br />
  Give the 3rd dose at least one week after the 2nd dose and at least one week before your trip. </p>
<p>It takes about 1 week after the last dose for protection to begin. 
For continuous protection, re-vaccination is recommended within 6 months. If less than 6 months 
have passed since the last vaccination a single dose will renew the protection. If more than 6 months 
have passed since the last vaccination, the primary vaccination (3 doses) should be repeated. </p>
<p>The suspensionsupplied in a single-dose glass vial is a whitish suspension. Each vial comes with one 
sachet package that contains a white effervescent powder of sodium hydrogen carbonate.  The 
effervescent powder should be dissolved in a glass of cool water, and the resulting buffer solution 
should be mixed with the suspension. It is important to use the buffer solution, as it protects the 
vaccine from the gastric acid. </p>
<p>Drink the entire mixture within 2 hours after mixing with the buffer solution. 
Instructions for use: </p>
<ol>
<li>
<p>To prepare the buffer solution, dissolve the effervescent powder in a glass of cool water 
(approx. 150 ml) by gently stirring.<br />
Do not use any other liquid. 
For children of 2 to below6 years: pour away half of the buffer solution.  </p>
</li>
<li>
<p>Shake the Dukoral  suspension vial (1 vial = 1 dose). </p>
</li>
<li>
<p>Pour the content of the Dukoral  suspension vial into the glass of buffer solution (see 1).<br />
Mix by gently stirring. </p>
</li>
<li>
<p>Drink the entire mixture within 2 hours. Avoid food and drink starting 1 hour before 
 until 1 hour after drinking the mixture.  </p>
</li>
</ol>
<p>If you take more Dukoral than you should 
If you take the doses less than one week apart, contact your doctor, pharmacist or nurse. 
Because each vial of Dukoral contains only one dose, overdosage is unlikely.<br />
If you have taken more than one dose at one time, please contact your doctor, pharmacist or nurse. 
If you forget to take Dukoral. 
You can take the 2nd dose of Dukoral up to 6 weeks after the 1st dose (children of 2 to below 6 years 
have to take 3 doses). If more than 6 weeks have passed, contact your doctor, pharmacist or nurse. </p>
<p>If you have any further questions on the use of this vaccine, ask your doctor, pharmacist or nurse. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, Dukoral can cause side effects, although not everybody gets them. 
Contact a doctor immediately if you experience the following serious side effects: 
  severe diarrhoea with loss of water from the body<br />
  serious allergic reactions causing swelling of the face or throat and breathlessness  </p>
<p>Other side effects: 
Uncommon side effects (may affect up to 1 in a 100 people)<br />
  Diarrhoea, stomach pain, stomach cramps, gurgling stomach, bloated stomach, stomach gas and 
general stomach discomfort<br />
  Headache </p>
<p>Rare side effects (may affect up to 1 in a 1,000 people) 
  Fever 
  Generally feeling unwell, feeling dizzy<br />
  Nausea (feeling sick), vomiting, loss of /or poor appetite 
   Swelling irritation inside the nose, and cough. </p>
<p>Very rare side effects (may affect up to 1 in a 10,000 people)<br />
  Rash<br />
  Sore throat, reduced sense of taste 
  Fatigue/feeling tired<br />
  Sweating, shivering 
  Joint pain 
  Difficulty in sleeping </p>
<p>Other side effects (frequency cannot be estimated from the available data) 
  Flu -like symptoms, chestiness, chills, general pain, weakness 
  Hives, itching 
  Swelling of the lymph glands 
  Numbness or pins and needles 
  High blood pressure </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side 
effects not listed in this leaflet. You can also report side effects directly via the national reporting 
system listed in Appendix V*. By reporting side effects you can help provide more information on the 
safety of this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store dukoral"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store dukoral"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. 
Do not use Dukoral after the expiry date which is stated on the carton after EXP. The expiry date 
refers to the last day of that month. 
Store in a refrigerator (2 C   8 C). Do not freeze. </p>
<p>Product in the unopened vial and sachet, stored in the outer carton, is stable at temperatures up to 
25oC for a period of 14 days. At the end of this period the product should be used or discarded. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Dukoral contains 
* The active substances are: 
31.25x109 bacteria<em> of each of the following V. cholerae O1 strains: Inaba classical biotype 
(heat inactivated), Inaba El Tor biotype (formalin inactivated), Ogawa classical biotype (heat 
inactivated), Ogawa classical biotype (formalin inactivated).<br />
Recombinant cholera toxin B subunit (rCTB) 1 mg. 
</em>bacterial content prior to inactivation </p>
<ul>
<li>
<p>The other ingredients in the vaccine suspension are sodium dihydrogen phosphate, disodium 
hydrogen phosphate, sodium chloride and water for injections. </p>
</li>
<li>
<p>The effervescent powder contains sodium hydrogen carbonate, citric acid, sodium carbonate, 
saccharin sodium, sodium citrate and raspberry flavour. </p>
</li>
</ul>
<p>What Dukoral looks like and contents of the pack 
Dukoral is presented as a suspension and effervescent powder for oral suspension. The suspension is a 
whitish suspension supplied in a vial. The effervescent powder is white with a raspberry flavour and 
is supplied in a sachet. </p>
<p>Dukoral is available in packs of 1, 2 and 20 doses. Not all pack sizes may be marketed. </p>
<p>Marketing Authorisation Holder<br />
Valneva Sweden AB, 105 21 Stockholm, Sweden.<br />
infodukoral@valneva.com </p>
<p>Manufacturer 
Valneva Sweden AB, Gunnar Asplunds all  16, SE-171 69 Solna, Sweden. </p>
<p>This leaflet was last revised in MM/YYYY </p>
<p>Other sources of information 
Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      



Instance: composition-da-a651c9ffaada5f4880461c8764acc607
InstanceOf: CompositionUvEpi
Title: "Composition for dukoral Package Leaflet"
Description:  "Composition for dukoral Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpa651c9ffaada5f4880461c8764acc607)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - dukoral"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen 
1. Virkning og anvendelse  <br />
2. Det skal De vide, før De begynder at tage Dukoral 
3. Sådan skal De tage Dukoral 
4. Bivirkninger 
5. Opbevaring 
6. Pakningsstørrelser og yderligere oplysninger </p>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What dukoral is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What dukoral is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dukoral er en oral vaccine mod kolera, der stimulerer immunforsvaret i tarmen. Vaccinen beskytter 
voksne og børn fra 2-års-alderen mod kolera. </p>
<p>Dukoral får kroppen til at danne sin egen beskyttelse mod kolera. Når De har fået vaccinen, danner 
Deres krop nogle stoffer, der kaldes antistoffer. Antistofferne bekæmper de kolerabakterier og det 
giftstof, der forårsager diaré.  </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take dukoral"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take dukoral"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Dukoral 
• hvis De er allergisk over for et af indholdsstofferne i vaccinen (angivet i afsnit 6) eller 
formaldehyd. 
• hvis De lider af akut mavesygdom eller infektion med feber (vaccinationen skal så udsættes). </p>
<p>Advarsler og forsigtighedsregler 
Kontakt lægen, før De tager Dukoral<br />
• hvis De tager et lægemiddel, der påvirker immunsystemet 
• hvis De har en sygdom i immunsystemet (f.eks. hiv-infektion).<br />
Vaccinen kan give Dem et lavere beskyttelsesniveau, end det giver personer med et rask 
immunsystem. </p>
<p>Vaccinen giver ikke fuldstændig beskyttelse, og det er vigtigt at overholde anbefalingerne vedrørende 
kost og hygiejne for at undgå diaré. </p>
<p>Børn 
Denne vaccine må ikke gives til børn under 2 år, da beskyttelsen ikke er undersøgt i denne gruppe. </p>
<p>Brug af anden medicin sammen med Dukoral 
Fortæl det altid til lægen, hvis De bruger anden medicin eller har gjort det for nylig. Tag ikke anden 
medicin fra 1 time før indtil 1 time efter indtagelse af vaccinen.  </p>
<p>Brug af Dukoral sammen med mad og drikke 
Undgå indtagelse af føde- og drikkevarer fra 1 time før indtil 1 time efter indtagelse af vaccinen. </p>
<p>Graviditet og amning 
Hvis De er gravid eller ammer, har mistanke om, at De er gravid eller planlægger at blive gravid, skal 
De spørge Deres læge til råds, før De tager vaccinen. </p>
<p>Trafik- og arbejdssikkerhed 
Der er ikke grund til at tro, at Dukoral vil påvirke Deres evne til at føre motorkøretøj elle betjene 
maskiner. </p>
<p>Dukoral indeholder natrium 
Dukoral indeholder ca. 1,1 g natrium pr. dosis. Hvis De er på natrium- eller saltfattig diæt, skal De 
tage hensyn hertil. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take dukoral"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take dukoral"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Brug altid dette lægemiddel nøjagtigt som beskrevet i denne indlægsseddel eller efter lægens 
anvisning. Er De i tvivl, så spørg lægen. </p>
<p>Voksne og børn fra 6 år: Den primære vaccination er 2 doser, der skal tages oralt (gennem munden) 
med mindst 1 uges (og op til 6 ugers) mellemrum.<br />
• Tag den første dosis senest 2 uger inden Deres rejse. 
• Tag den anden dosis mindst 1 uge efter den første dosis og mindst 1 uge inden Deres rejse.<br />
Det tager cirka 1 uge efter den sidste dosis, før beskyttelsen sætter ind. Af hensyn til den fortsatte 
beskyttelse anbefales en ny vaccination inden for 2 år. Hvis De har fået Deres sidste dosis af vaccinen 
mindre end 2 år tidligere, vil en enkelt dosis kunne forny beskyttelsen. Hvis der er forløbet mere end 2 
år siden Deres sidste vaccinedosis, bør den primære vaccination (2 doser) gentages. </p>
<p>Børn fra 2 til under 6 år: Den primære vaccination er 3 doser, der skal tages oralt (gennem munden) 
med mindst 1 uges (og op til 6 ugers) mellemrum. Kun halvdelen af bufferopløsningen skal blandes 
med vaccinen.<br />
• Giv barnet den første dosis senest 3 uger inden Deres rejse. 
• Giv barnet den anden dosis mindst 1 uge efter den første dosis. 
• Giv barnet den tredje dosis mindst 1 uge efter den anden dosis og mindst 1 uge inden Deres 
rejse.<br />
Det tager cirka 1 uge efter den sidste dosis, før beskyttelsen sætter ind.<br />
Af hensyn til den fortsatte beskyttelse anbefales en ny vaccination inden for 6 måneder. Hvis De har 
fået Deres sidste dosis af vaccinen mindre end 6 måneder tidligere, er, vil en enkelt dosis kunne forny 
beskyttelsen. Hvis der er forløbet mere end 6 måneder siden Deres sidste vaccinedosis, bør den 
primære vaccination (3 doser) gentages. </p>
<p>Suspensionen, der leveres i et hætteglas med en enkelt dosis, er en hvidlig opslæmning (suspension). 
Hvert hætteglas leveres sammen med et brev, der indeholder et hvidt brusepulver med 
natriumhydrogencarbonat. Brusepulveret skal opløses i et glas koldt vand, og suspensionen skal 
blandes med den dermed fremstillede bufferopløsning. Det er vigtigt at bruge bufferopløsningen, da 
den beskytter vaccinen mod mavesyren.  </p>
<p>Hele blandingen skal drikkes inden for 2 timer efter opblanding med bufferopløsningen. </p>
<p>Brugsanvisning: </p>
<ol>
<li>
<p>Bufferopløsningen fremstilles ved at opløse brusepulveret i et glas koldt vand (cirka 150 ml) ved 
forsigtig omrøring.<br />
Brug ikke nogen anden væske. 
Til børn i alderen fra 2 til under 6 år: Halvdelen af bufferopløsningen kasseres. </p>
</li>
<li>
<p>Hætteglasset med Dukoral® suspension omrystes (1 hætteglas = 1 dosis). </p>
</li>
<li>
<p>Hæld indholdet af hætteglasset med Dukoral® suspension i glasset med bufferopløsning (se 1). 
Blandes ved at omrøre forsigtigt.  </p>
</li>
<li>
<p>Drik hele blandingen inden for 2 timer. Undgå mad og drikke fra 1 time inden og indtil 1 time efter 
indtagelse af blandingen. </p>
</li>
</ol>
<p>Hvis De har taget for meget Dukoral 
Kontakt Deres læge, apotekspersonalet eller sundhedspersonalet, hvis De har taget doserne med 
mindre end 1 uges mellemrum. 
Overdosering er usandsynligt, da hvert hætteglas med Dukoral kun indeholder én dosis.<br />
Kontakt Deres læge, apotekspersonalet eller sundhedspersonalet, hvis De har taget mere end én dosis 
på en gang. </p>
<p>Hvis De har glemt at tage Dukoral 
De kan tage den anden dosis af Dukoral op til 6 uger efter den første dosis (børn fra 2 til under 6 år 
skal tage 3 doser). Kontakt Deres læge, apotekspersonalet eller sundhedspersonalet, hvis der er 
forløbet mere end 6 uger. </p>
<p>Spørg lægen, apotekspersonalet eller sundhedspersonalet, hvis der er noget, De er i tvivl om. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som al anden medicin give bivirkninger, men ikke alle får bivirkninger. </p>
<p>Kontakt straks en læge, hvis De får følgende alvorlige bivirkninger: 
• kraftig diaré med væsketab fra kroppen 
• alvorlige allergiske reaktioner, der medfører hævelse i ansigt eller hals samt åndedrætsbesvær </p>
<p>Andre bivirkninger: </p>
<p>Ikke almindelige bivirkninger (kan ramme op til 1 ud af 100 personer)<br />
• Diaré, mavepine, mavekramper, skvulpen i maven, oppustet mave, luft i maven, generelt 
ubehag i maven </p>
<p>• Hovedpine. </p>
<p>Sjældne bivirkninger (kan ramme op til 1 ud af 1.000 personer) 
• Feber<br />
• Generel utilpashed, svimmelhed 
• Kvalme, opkastning, ingen appetit/nedsat appetit<br />
• Hævelse og irritation i næsen samt hoste. </p>
<p>Meget sjældne bivirkninger (kan ramme op til 1 ud af 10.000 personer) 
• Udslæt 
• Halssmerter, nedsat smagssans<br />
• Udmattethed, træthed 
• Svedtendens skælven 
• Ledsmerter 
• Søvnbesvær. </p>
<p>Andre bivirkninger (hyppigheden kan ikke vurderes ud fra tilgængelige data) 
• Influenzalignende symptomer, symptomer fra luftvejene, kulderystelser, generelle smerter, 
svaghed 
• Nældefeber, kløe 
• Hævede lymfekirtler 
• Følelsesløshed eller snurrende og prikkende fornemmelse 
• Forhøjet blodtryk. </p>
<p>Indberetning af bivirkninger 
Hvis De oplever bivirkninger, bør De tale med Deres læge, sygeplejerske eller apoteket. Dette gælder 
også mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. De eller Deres pårørende kan 
også indberette bivirkninger direkte til Sundhedsstyrelsen via det nationale rapporteringssystem anført 
i Appendiks V. Ved at indrapportere bivirkninger kan De hjælpe med at fremskaffe mere information 
om sikkerheden af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store dukoral"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store dukoral"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar lægemidlet utilgængeligt for børn. 
Brug ikke Dukoral efter den udløbsdato, der står på pakningen efter EXP. Udløbsdatoen er den sidste 
dag i den nævnte måned. 
Opbevares i køleskab (2°C - 8°C). Må ikke nedfryses. </p>
<p>I uåbnet hætteglas og brev og opbevaret i den ydre karton er præparatet stabilt ved temperaturer op til 
25oC i en periode på 14 dage. Efter denne periode skal præparatet anvendes eller kasseres. </p>
<p>Spørg på apoteket, hvordan De skal bortskaffe medicinrester. Af hensyn til miljøet må De ikke smide 
medicinrester i afløbet, toilettet eller skraldespanden. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dukoral indeholder: </p>
<ul>
<li>Aktive stoffer: 
31,25x109 bakterier* af hver af følgende V. cholerae O1-stammer: Inaba klassisk biotype 
(varme-inaktiveret), Inaba El Tor biotype (formalin-inaktiveret), Ogawa klassisk biotype 
(varme-inaktiveret), Ogawa klassisk biotype (formalin-inaktiveret).<br />
Rekombinant koleratoksin B-subenhed (rCTB) 1 mg. </li>
</ul>
<p>*bakterieindhold inden inaktivering </p>
<ul>
<li>
<p>Øvrige indholdsstoffer i vaccinesuspensionen: natriumdihydrogenphosphat, 
dinatriumhydrogenphosphat, natriumchlorid og vand til injektionsvæsker. </p>
</li>
<li>
<p>Brusepulveret indeholder natriumhydrogencarbonat, citronsyre, natriumcarbonat, 
saccharinnatrium, natriumcitrat og hindbæraroma. </p>
</li>
</ul>
<p>Udseende og pakningsstørrelser 
Dukoral leveres som en suspension og brusepulver til oral suspension. Suspensionen er en hvidlig 
suspension i et hætteglas. Brusepulveret er hvidt med hindbæraroma og leveres i et brev. </p>
<p>Dukoral fås i pakninger med 1, 2 og 20 doser. Ikke alle pakningsstørrelser er nødvendigvis 
markedsført. </p>
<p>Indehaver af markedsføringstilladelsen<br />
Valneva Sweden AB, 105 21 Stockholm, Sverige.<br />
infodukoral@valneva.com </p>
<p>Fremstiller 
Valneva Sweden AB, Gunnar Asplunds allé 16, SE-171 69 Solna, Sverige.  </p>
<p>Denne indlægsseddel blev senest ændret MM/ÅÅÅÅ </p>
<p>Andre informationskilder 
De kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside http://www.ema.europa.eu/.  </p>
<p>Denne indlægsseddel findes på alle EU-/EØS-sprog på Det Europæiske Lægemiddelagenturs 
hjemmeside.  </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-a651c9ffaada5f4880461c8764acc607
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for dukoral Package Leaflet for language en"
Description: "ePI document Bundle for dukoral Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-a651c9ffaada5f4880461c8764acc607"
* entry[0].resource = composition-en-a651c9ffaada5f4880461c8764acc607

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpa651c9ffaada5f4880461c8764acc607"
* entry[=].resource = mpa651c9ffaada5f4880461c8764acc607
                            
                    
Instance: bundlepackageleaflet-da-a651c9ffaada5f4880461c8764acc607
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for dukoral Package Leaflet for language da"
Description: "ePI document Bundle for dukoral Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-a651c9ffaada5f4880461c8764acc607"
* entry[0].resource = composition-da-a651c9ffaada5f4880461c8764acc607

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpa651c9ffaada5f4880461c8764acc607"
* entry[=].resource = mpa651c9ffaada5f4880461c8764acc607
                            
                    



Instance: mpa651c9ffaada5f4880461c8764acc607
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Dukoral suspension and effervescent powder for oral suspension"
Description: "Dukoral suspension and effervescent powder for oral suspension"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/03/263/001-003"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Dukoral suspension and effervescent powder for oral suspension"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: a651c9ffaada5f4880461c8764acc607ListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "dukoral"

* status = #current
* mode = #working

* title = "List of all ePIs associated with dukoral"

* subject = Reference(mpa651c9ffaada5f4880461c8764acc607)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#dukoral "dukoral"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-a651c9ffaada5f4880461c8764acc607) // dukoral en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-a651c9ffaada5f4880461c8764acc607) // dukoral da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-a651c9ffaada5f4880461c8764acc607
InstanceOf: List

* insert a651c9ffaada5f4880461c8764acc607ListRuleset
    